182 related articles for article (PubMed ID: 7869744)
1. Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity.
Jahn B; Bergmann L; Weidmann E; Brieger J; Fenchel K; Schwulera U; Hoelzer D; Mitrou PS
Leuk Res; 1995 Feb; 19(2):73-82. PubMed ID: 7869744
[TBL] [Abstract][Full Text] [Related]
2. Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia.
Weidmann E; Brieger J; Jahn B; Hoelzer D; Bergmann L; Mitrou PS
Ann Hematol; 1995 Mar; 70(3):153-8. PubMed ID: 7718644
[TBL] [Abstract][Full Text] [Related]
3. Extrathymic development and function of human T-lymphocytes from bone marrow cells in vitro.
Adibzadeh M; Bühring HJ; Daikeler T; Siegels-Hübenthal P; Owsianowsky M; Schenk A; Rehbein A; Schaudt K; Schlotz E; Pohla H
Cell Immunol; 1994 Mar; 154(1):25-42. PubMed ID: 8118889
[TBL] [Abstract][Full Text] [Related]
4. Culture of normal and leukemic bone marrow in interleukin-2: analysis of cell activation, cell proliferation, and cytokine production.
Klingemann HG; Neerunjun J; Schwulera U; Ziltener HJ
Leukemia; 1993 Sep; 7(9):1389-93. PubMed ID: 8371589
[TBL] [Abstract][Full Text] [Related]
5. Evolution of a CD3+CD4+ alpha/beta T-cell receptor+ mature T-cell clone from CD3-CD7+ sorted human bone marrow cells.
Pohla H; Adibzadeh M; Bühring HJ; Siegels-Hübenthal P; Deikeler T; Owsianowsky M; Schenk A; Rehbein A; Schlotz E; Schaudt K
Dev Immunol; 1993; 3(3):197-210. PubMed ID: 7506598
[TBL] [Abstract][Full Text] [Related]
6. Antigen specific and MHC nonrestricted cytotoxicity of T cell receptor alpha beta+ and gamma delta+ human T cell clones isolated in IL-4.
Paliard X; Yssel H; Blanchard D; Waitz JA; deVries JE; Spits H
J Immunol; 1989 Jul; 143(2):452-7. PubMed ID: 2472439
[TBL] [Abstract][Full Text] [Related]
7. Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms.
Correale J; Rojany M; Weiner LP
J Neuroimmunol; 1997 Dec; 80(1-2):47-64. PubMed ID: 9413259
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the functional capabilities of CD3+CD4-CD8- and CD3+CD4+CD8+ human T cell clones.
Patel SS; Wacholtz MC; Duby AD; Thiele DL; Lipsky PE
J Immunol; 1989 Aug; 143(4):1108-17. PubMed ID: 2526180
[TBL] [Abstract][Full Text] [Related]
9. Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype.
Gattorno M; Facchetti P; Ghiotto F; Vignola S; Buoncompagni A; Prigione I; Picco P; Pistoia V
Clin Exp Immunol; 1997 Jul; 109(1):4-11. PubMed ID: 9218817
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells.
Schoof DD; Terashima Y; Peoples GE; Goedegebuure PS; Andrews JV; Richie JP; Eberlein TJ
Cell Immunol; 1993 Aug; 150(1):114-23. PubMed ID: 8102084
[TBL] [Abstract][Full Text] [Related]
11. Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: neuroblastoma.
Facchetti P; Prigione I; Ghiotto F; Tasso P; Garaventa A; Pistoia V
Cancer Immunol Immunother; 1996 Mar; 42(3):170-8. PubMed ID: 8640845
[TBL] [Abstract][Full Text] [Related]
12. CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT.
Steger B; Milosevic S; Doessinger G; Reuther S; Liepert A; Braeu M; Schick J; Vogt V; Schuster F; Kroell T; Busch DH; Borkhardt A; Kolb HJ; Tischer J; Buhmann R; Schmetzer H
Immunobiology; 2014 Apr; 219(4):247-60. PubMed ID: 24315637
[TBL] [Abstract][Full Text] [Related]
13. Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture.
Ciccone E; Viale O; Bottino C; Pende D; Migone N; Casorati G; Tambussi G; Moretta A; Moretta L
J Exp Med; 1988 Apr; 167(4):1517-22. PubMed ID: 2965741
[TBL] [Abstract][Full Text] [Related]
14. T-cell clones that react against autologous human tumors.
Mukherji B; Chakraborty NG; Sivanandham M
Immunol Rev; 1990 Aug; 116():33-62. PubMed ID: 2146210
[TBL] [Abstract][Full Text] [Related]
15. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL
J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cells with T cell markers in athymic nude bone marrow and of their in vitro-derived clonal progeny. Comparison with euthymic bone marrow.
Benveniste P; Chadwick BS; Miller RG; Reimann J
J Immunol; 1990 Jan; 144(2):411-9. PubMed ID: 2136889
[TBL] [Abstract][Full Text] [Related]
17. Functional and phenotypic differences between CD4+ and CD4- T cell receptor-gamma delta clones from peripheral blood.
Spits H; Paliard X; Vandekerckhove Y; van Vlasselaer P; de Vries JE
J Immunol; 1991 Aug; 147(4):1180-8. PubMed ID: 1831219
[TBL] [Abstract][Full Text] [Related]
18. Human CD3 gamma delta + activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells.
Bensussan A; Lagabrielle JF; Castaigne S; Boisson N; Miclea JM; Benbunan M; Degos L
Nouv Rev Fr Hematol (1978); 1989; 31(2):129-32. PubMed ID: 2528119
[TBL] [Abstract][Full Text] [Related]
19. Specific recognition of human leukemic cells by allogeneic T cell lines.
Sosman JA; Oettel KR; Hank JA; Fisch P; Sondel PM
Transplantation; 1989 Sep; 48(3):486-95. PubMed ID: 2571206
[TBL] [Abstract][Full Text] [Related]
20. Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts; studies of normal polyclonal T cells and T lymphocyte clones derived early after allogenic bone marrow transplantation.
Bruserud O; Pawelec G
Cancer Immunol Immunother; 1996 Mar; 42(3):133-40. PubMed ID: 8640841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
